David has worked in the pharmaceutical industry since 1992 and has been the Managing Director of BNM since 2009. David oversaw the growth of BNM from a predominantly South Pacific Islands focused company to one which now produces 75% of its revenue from the Australian and New Zealand markets. Having sold the business to ADVANZ PHARMA in 2015 and together with the support of his talented and energetic team, David continues to grow and develop the business in these markets.
Abdul has worked in the pharmaceutical industry since 1991, including both the public and private sectors. Abdul joined the business in 2001 and as the Business Development Director for BNM oversees the growth of BNM’s product portfolio in both Australia and New Zealand. Other than business development, Abdul is involved in identifying and developing strategic partnerships in order to capitalise on BNM’s core competencies and help deliver the required commercial outcomes.
Peter joined the company in 2006. In his current role, Peter is responsible for overseeing financial, management reporting and treasury for the entire Australasia region. Peter is a CPA certified accountant with over 15 years of collective experience in the accounting sector. He holds a Bachelor of Mathematics & Finance and a bridging degree in accounting from the University of Technology Sydney.
Monika is a pharmacist with 20 years of experience in the registration of medicines with the TGA in Australia and Medsafe in New Zealand. Prior to joining BNM in 2010 as the Regulatory Affairs Manager, she worked with a number of different organisations including innovative and generic medicine manufacturers and a Clinical Research Organisation (CRO). Launching with one Australian product registration, the Australia and New Zealand portfolio now comprises more than 50 molecules.
Kathia joined BNM in 2009 managing sales and distribution of a wide range of in-licensed BNM group brands. As the Commercial Manager, she manages our strategic partners in Australia, including multinational pharmaceutical companies, and provides commercial and promotional support to our third-party sales force. Kathia is responsible for a portfolio of over 100 product lines in the region and expanding our local presence via strategic partnerships and developing key networks in the retail sector.
For information on our Corporate Management Team and Board of Directors, please visit www.advanzpharma.com/about.